PAS-004

· Pasithea Therapeutics Corp.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PAS-004, covering 2025-12-03 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas [Phase 1]